Pdl Biopharma, Inc.

CIK 882104 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Pdl Biopharma, Inc..

Recent SEC filings

FiledFormAccession number
Aug 13, 2026SCHEDULE 13G0001015079-26-000085
Feb 9, 2024SC 13G/A0000354204-24-003033
Feb 10, 2023SC 13G/A0000354204-23-001434
Feb 8, 2022SC 13G/A0000354204-22-001597
Mar 29, 202110-K0000882104-21-000035
Feb 19, 2021SC TO-I/A0000882104-21-000030
Feb 12, 2021SC 13G/A0000354204-21-000192
Feb 11, 2021SC 13G/A0001104659-21-020719
Feb 11, 2021SC 13G/A0001037389-21-000129
Feb 3, 2021EFFECT9999999995-21-000399
Feb 3, 2021EFFECT9999999995-21-000402
Feb 3, 2021EFFECT9999999995-21-000403
Feb 3, 2021EFFECT9999999995-21-000400
Feb 3, 2021EFFECT9999999995-21-000398
Feb 3, 2021EFFECT9999999995-21-000401
Feb 3, 202140001123292-21-000156
Feb 3, 2021EFFECT9999999995-21-000428
Feb 2, 2021POS AM0000882104-21-000026
Feb 2, 2021POS AM0000882104-21-000028
Feb 2, 2021POS AM0000882104-21-000025
Feb 2, 2021POS AM0000882104-21-000022
Feb 2, 2021POS AM0000882104-21-000024
Feb 2, 2021POS AM0000882104-21-000023
Feb 2, 2021POS AM0000882104-21-000027
Feb 1, 2021EFFECT9999999995-21-000362